PFIZER INC Deferred Tax Liabilities, Net
PFIZER INC (PFE) had Deferred Tax Liabilities, Net of $3.12 billion as of 2020-12-31, per its 10-K filed 2022-02-24.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxLiabilities · last filed 2022-02-24
- 2020-12-31: Deferred Tax Liabilities, Net $3.12B.
- 2019-12-31: Deferred Tax Liabilities, Net $4.96B; Deferred Tax Liabilities, Net as first filed $4.70B.
- 2018-12-31: Deferred Tax Liabilities, Net $2.95B.
- 2017-12-31: Deferred Tax Liabilities, Net $3.24B.
| Period end | Deferred Tax Liabilities, Net | Deferred Tax Liabilities, Net as first filed |
|---|---|---|
| 2020-12-31 | $3.12B 10-K · filed 2022-02-24 | |
| 2019-12-31 | $4.96B 10-K · filed 2021-02-25 | $4.70B 10-K · filed 2020-02-27 |
| 2018-12-31 | $2.95B 10-K · filed 2020-02-27 | |
| 2017-12-31 | $3.24B 10-K · filed 2019-02-28 | |
| 2016-12-31 | $30.10B 10-K · filed 2018-02-22 | |
| 2015-12-31 | $26.14B 10-K · filed 2017-02-23 | |
| 2014-12-31 | $22.40B 10-K · filed 2016-02-29 | |
| 2013-12-31 | $22.96B 10-K · filed 2015-02-27 | |
| 2012-12-31 | $17.06B 10-K · filed 2014-02-28 | $33.26B 10-K · filed 2013-02-28 |
| 2011-12-31 | $29.31B 10-K · filed 2013-02-28 | $30.05B 10-K · filed 2012-02-28 |
| 2010-12-31 | $29.63B 10-K · filed 2012-02-28 | -$29.65B 10-K · filed 2011-02-28 |
| 2009-12-31 | -$30.05B 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |